123 related articles for article (PubMed ID: 38061274)
1. Impact of the COVID-19 pandemic on cancer screenings in Portugal.
Mendes D; Figueiredo D; Alves C; Penedones A; Costa B; Batel-Marques F
Cancer Epidemiol; 2024 Feb; 88():102496. PubMed ID: 38061274
[TBL] [Abstract][Full Text] [Related]
2. Model-Based Estimation of Colorectal Cancer Screening and Outcomes During the COVID-19 Pandemic.
Issaka RB; Taylor P; Baxi A; Inadomi JM; Ramsey SD; Roth J
JAMA Netw Open; 2021 Apr; 4(4):e216454. PubMed ID: 33843997
[TBL] [Abstract][Full Text] [Related]
3. Trends of Cancer Screenings, Diagnoses, and Mortalities During the COVID-19 Pandemic: Implications and Future Recommendations.
Concepcion J; Yeager M; Alfaro S; Newsome K; Ibrahim J; Bilski T; Elkbuli A
Am Surg; 2023 Jun; 89(6):2276-2283. PubMed ID: 35420510
[TBL] [Abstract][Full Text] [Related]
4. Impact of the COVID-19 pandemic on faecal immunochemical test-based colorectal cancer screening programmes in Australia, Canada, and the Netherlands: a comparative modelling study.
de Jonge L; Worthington J; van Wifferen F; Iragorri N; Peterse EFP; Lew JB; Greuter MJE; Smith HA; Feletto E; Yong JHE; Canfell K; Coupé VMH; Lansdorp-Vogelaar I;
Lancet Gastroenterol Hepatol; 2021 Apr; 6(4):304-314. PubMed ID: 33548185
[TBL] [Abstract][Full Text] [Related]
5. Cancer Screening Disparities Before and After the COVID-19 Pandemic.
Lofters AK; Wu F; Frymire E; Kiran T; Vahabi M; Green ME; Glazier RH
JAMA Netw Open; 2023 Nov; 6(11):e2343796. PubMed ID: 37983033
[TBL] [Abstract][Full Text] [Related]
6. Cancer incidence and mortality in Australia from 2020 to 2044 and an exploratory analysis of the potential effect of treatment delays during the COVID-19 pandemic: a statistical modelling study.
Luo Q; O'Connell DL; Yu XQ; Kahn C; Caruana M; Pesola F; Sasieni P; Grogan PB; Aranda S; Cabasag CJ; Soerjomataram I; Steinberg J; Canfell K
Lancet Public Health; 2022 Jun; 7(6):e537-e548. PubMed ID: 35660215
[TBL] [Abstract][Full Text] [Related]
7. Years of life lost by COVID-19 in Portugal and comparison with other European countries in 2020.
Vieira A; Ricoca VP; Aguiar P; Sousa P; Nunes C; Abrantes A
BMC Public Health; 2021 Jun; 21(1):1054. PubMed ID: 34078348
[TBL] [Abstract][Full Text] [Related]
8. COVID-19 and inequities in colorectal and cervical cancer screening and diagnosis in Washington State.
Amram O; Amiri S; Robison J; Pflugeisen CM; Monsivais P
Cancer Med; 2022 Aug; 11(15):2990-2998. PubMed ID: 35304835
[TBL] [Abstract][Full Text] [Related]
9. Modeling Strategies to Optimize Cancer Screening in USPSTF Guideline-Noncompliant Women.
Taksler GB; Peterse EFP; Willems I; Ten Haaf K; Jansen EEL; de Kok IMCM; van Ravesteyn NT; de Koning HJ; Lansdorp-Vogelaar I
JAMA Oncol; 2021 Jun; 7(6):885-894. PubMed ID: 33914025
[TBL] [Abstract][Full Text] [Related]
10. A national quality improvement study identifying and addressing cancer screening deficits due to the COVID-19 pandemic.
Joung RH; Nelson H; Mullett TW; Kurtzman SH; Shafir S; Harris JB; Yao KA; Brajcich BC; Bilimoria KY; Cance WG
Cancer; 2022 Jun; 128(11):2119-2125. PubMed ID: 35307815
[TBL] [Abstract][Full Text] [Related]
11. Association of Cancer Screening Deficit in the United States With the COVID-19 Pandemic.
Chen RC; Haynes K; Du S; Barron J; Katz AJ
JAMA Oncol; 2021 Jun; 7(6):878-884. PubMed ID: 33914015
[TBL] [Abstract][Full Text] [Related]
12. The impact of COVID-19 on screening for colorectal, gastric, breast, and cervical cancer in Korea.
Park H; Seo SH; Park JH; Yoo SH; Keam B; Shin A
Epidemiol Health; 2022; 44():e2022053. PubMed ID: 35760396
[TBL] [Abstract][Full Text] [Related]
13. Japanese cancer screening programs during the COVID-19 pandemic: Changes in participation between 2017-2020.
Machii R; Takahashi H
Cancer Epidemiol; 2023 Feb; 82():102313. PubMed ID: 36508964
[TBL] [Abstract][Full Text] [Related]
14. Understanding COVID-19 impact on cervical, breast, and colorectal cancer screening among federally qualified healthcare centers participating in "Back on track with screening" quality improvement projects.
Fisher-Borne M; Isher-Witt J; Comstock S; Perkins RB
Prev Med; 2021 Oct; 151():106681. PubMed ID: 34217422
[TBL] [Abstract][Full Text] [Related]
15. Picturing Prevalence and Inequalities in Cancer Screening Attendance to Population-Based Programs in Portugal.
Quintal C; Antunes M
Acta Med Port; 2023 Sep; 36(9):577-587. PubMed ID: 37339163
[TBL] [Abstract][Full Text] [Related]
16. Impact of COVID-19 control on lung, breast, and colorectal pathological cancer diagnoses. A comparison between the Netherlands, Aotearoa New Zealand, and Northern Ireland.
Mitchell H; Mclean J; Gavin AT; Visser O; Millar E; Luff T; Bennett D
BMC Cancer; 2023 Jul; 23(1):700. PubMed ID: 37495980
[TBL] [Abstract][Full Text] [Related]
17. Projected long-term effects of colorectal cancer screening disruptions following the COVID-19 pandemic.
Nascimento de Lima P; van den Puttelaar R; Hahn AI; Harlass M; Collier N; Ozik J; Zauber AG; Lansdorp-Vogelaar I; Rutter CM
Elife; 2023 May; 12():. PubMed ID: 37129468
[TBL] [Abstract][Full Text] [Related]
18. Global Association of COVID-19 Pandemic Measures With Cancer Screening: A Systematic Review and Meta-analysis.
Teglia F; Angelini M; Astolfi L; Casolari G; Boffetta P
JAMA Oncol; 2022 Sep; 8(9):1287-1293. PubMed ID: 35797056
[TBL] [Abstract][Full Text] [Related]
19. The impact of COVID-19 on national program of colorectal cancer screening in Tehran, Iran: a multicenter study.
Sadeghi A; Asadzadeh Aghdaei H; Khalafi MA; Nazemalhosseini-Mojarad E; Ketabi Moghadam P; Sohrabi MR
BMC Cancer; 2023 Jul; 23(1):627. PubMed ID: 37407931
[TBL] [Abstract][Full Text] [Related]
20. A population-based survey of self-reported delays in breast, cervical, colorectal and lung cancer screening.
Gunn CM; Berrian K; Weiss JE; Tosteson AAN; Hasson RM; Di Florio-Alexander R; Peacock JL; Rees JR
Prev Med; 2023 Oct; 175():107649. PubMed ID: 37517458
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
